NASDAQ:CYNO - Cynosure Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$66.00 0.00 (0.00 %)
(As of 05/22/2018 04:00 PM ET)
Previous Close$66.00
Today's Range$66.00 - $66.00
52-Week Range$39.90 - $66.65
VolumeN/A
Average Volume1.24 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Cynosure (NASDAQ:CYNO)

Cynosure logoCynosure, Inc. develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women's health. The Company also markets radiofrequency (RF), energy-sourced medical devices for surgical applications, such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. The Company sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names. Its product portfolio includes single energy source systems, as well as workstations that incorporate two or more different types of lasers or light-based technologies.

Receive CYNO News and Ratings via Email

Sign-up to receive the latest news and ratings for CYNO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNASDAQ:CYNO
CUSIP23257720
Phone+1-978-2564200

Debt

Debt-to-Equity Ratio0.04
Current Ratio3.28
Quick Ratio2.54

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins0.70%
Return on Equity0.75%
Return on Assets0.59%

Miscellaneous

Employees857
Outstanding Shares24,350,000

Cynosure (NASDAQ:CYNO) Frequently Asked Questions

What is Cynosure's stock symbol?

Cynosure trades on the NASDAQ under the ticker symbol "CYNO."

How were Cynosure's earnings last quarter?

Cynosure, Inc. (NASDAQ:CYNO) issued its earnings results on Tuesday, July, 26th. The medical equipment provider reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.07. The medical equipment provider earned $110.30 million during the quarter, compared to analyst estimates of $101.31 million. Cynosure had a net margin of 0.70% and a return on equity of 0.75%. The company's quarterly revenue was up 31.8% on a year-over-year basis. During the same quarter last year, the business earned $0.30 earnings per share. View Cynosure's Earnings History.

Has Cynosure been receiving favorable news coverage?

News headlines about CYNO stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cynosure earned a daily sentiment score of 0.09 on Accern's scale. They also assigned news coverage about the medical equipment provider an impact score of 46.42 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Cynosure?

Shares of CYNO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cynosure's stock price today?

One share of CYNO stock can currently be purchased for approximately $66.00.

How can I contact Cynosure?

Cynosure's mailing address is 5 Carlisle Rd, WESTFORD, MA 01886-3601, United States. The medical equipment provider can be reached via phone at +1-978-2564200.


MarketBeat Community Rating for Cynosure (CYNO)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  251 (Vote Outperform)
Underperform Votes:  140 (Vote Underperform)
Total Votes:  391
MarketBeat's community ratings are surveys of what our community members think about Cynosure and other stocks. Vote "Outperform" if you believe CYNO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYNO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cynosure (NASDAQ:CYNO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AHoldHold
Consensus Rating Score: N/AN/A2.002.25
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/A$66.00$58.00
Price Target Upside: N/AN/A0.00% downside12.12% downside

Cynosure (NASDAQ:CYNO) Consensus Price Target History

Price Target History for Cynosure (NASDAQ:CYNO)

Cynosure (NASDAQ:CYNO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/28/2017AegisReiterated RatingHold$66.00N/AView Rating Details
2/16/2017Northland SecuritiesReiterated RatingOutperform$60.00N/AView Rating Details
2/14/2017Northcoast ResearchUpgradeSell ➝ NeutralN/AView Rating Details
2/14/2017Maxim GroupDowngradeBuy ➝ Hold$66.00N/AView Rating Details
10/28/2016Leerink SwannReiterated RatingOutperform$63.00 ➝ $60.00N/AView Rating Details
10/26/2016Stifel NicolausReiterated RatingBuy$62.00 ➝ $58.00N/AView Rating Details
10/24/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 5/22/2016 forward)

Earnings

Cynosure (NASDAQ:CYNO) Earnings History and Estimates Chart

Earnings by Quarter for Cynosure (NASDAQ:CYNO)

Cynosure (NASDAQ:CYNO) Earnings Estimates

2018 EPS Consensus Estimate: $2.02
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.34$0.34$0.34
Q2 20181$0.51$0.51$0.51
Q3 20181$0.50$0.50$0.50
Q4 20181$0.67$0.67$0.67

Cynosure (NASDAQ CYNO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2017Q416$0.41$0.44$119.97 million$122.10 millionViewListenView Earnings Details
10/25/2016Q316$0.28$0.29$101.11 million$106.40 millionViewListenView Earnings Details
7/26/2016Q216$0.29$0.36$101.31 million$110.30 millionViewListenView Earnings Details
4/26/2016Q116$0.14$0.19$85.78 million$94.70 millionViewListenView Earnings Details
2/9/2016Q415$0.36$0.42$95.01 million$102.40 millionViewListenView Earnings Details
10/27/2015Q315$0.18$0.21$76.68 million$78.40 millionViewListenView Earnings Details
7/28/2015Q215$0.27$0.30$82.71 million$83.70 millionViewListenView Earnings Details
5/5/2015Q1$0.17$0.15$70.87 million$74.90 millionViewListenView Earnings Details
2/10/2015Q414$0.39$0.36$83.01 million$86.30 millionViewListenView Earnings Details
10/28/2014Q314$0.24$0.25$69.94 million$71.50 millionViewListenView Earnings Details
7/29/2014Q214$0.30$0.32$71.15 million$72.60 millionViewListenView Earnings Details
5/6/2014Q1$0.23$0.19$64.70 million$62.00 millionViewListenView Earnings Details
2/12/2014Q413$0.19$0.39$67.80 million$74.50 millionViewListenView Earnings Details
10/29/2013Q313$0.19$0.23$61.60 million$60.70 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.20$0.29$46.96 million$50.09 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.13$0.12$38.51 million$10.70 millionViewListenView Earnings Details
2/12/2013Q4 2012$0.23$0.27$40.98 million$47.70 millionViewListenView Earnings Details
10/23/2012$0.12$0.25ViewN/AView Earnings Details
7/24/2012$0.12$0.20ViewN/AView Earnings Details
5/1/2012($0.02)$0.06ViewN/AView Earnings Details
2/14/2012$0.05$0.08ViewN/AView Earnings Details
10/25/2011$0.04($0.06)ViewN/AView Earnings Details
7/26/2011Q2 2011($0.03)($0.01)ViewN/AView Earnings Details
5/3/2011($0.05)($0.15)ViewN/AView Earnings Details
2/15/2011($0.03)($0.06)ViewN/AView Earnings Details
10/26/2010Q3 2010($0.10)($0.04)ViewN/AView Earnings Details
7/27/2010Q2 2010($0.09)($0.12)ViewN/AView Earnings Details
5/4/2010Q1 2010($0.15)($0.22)ViewN/AView Earnings Details
2/9/2010Q4 2009($0.11)($0.16)ViewN/AView Earnings Details
10/27/2009Q3 2009($0.17)($0.15)ViewN/AView Earnings Details
7/28/2009Q2 2009($0.16)($0.18)ViewN/AView Earnings Details
5/5/2009Q1 2009$0.02($0.32)ViewN/AView Earnings Details
2/10/2009Q4 2008($0.15)($0.19)ViewN/AView Earnings Details
10/28/2008Q3 2008$0.38$0.37ViewN/AView Earnings Details
7/29/2008Q2 2008$0.36$0.36ViewN/AView Earnings Details
4/29/2008Q1 2008$0.31$0.38ViewN/AView Earnings Details
2/12/2008Q4 2007$0.36$0.41ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Cynosure (NASDAQ:CYNO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Cynosure (NASDAQ CYNO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.90%
Insider Trading History for Cynosure (NASDAQ:CYNO)
Insider Trading History for Cynosure (NASDAQ:CYNO)

Cynosure (NASDAQ CYNO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2016Douglas J DelaneyVPSell7,875$45.00$354,375.005,833View SEC Filing  
11/22/2016Michael R DavinChairmanSell16,284$45.00$732,780.004,222View SEC Filing  
8/30/2016Brian M BarefootDirectorSell21,000$51.66$1,084,860.005,000View SEC Filing  
8/15/2016Michael R DavinChairmanSell12,062$53.35$643,507.7012,062View SEC Filing  
8/15/2016Timothy W BakerCFOSell5,834$53.35$311,243.905,834View SEC Filing  
8/11/2016Michael R DavinChairmanSell4,222$53.18$224,525.964,222View SEC Filing  
8/11/2016Timothy W BakerCFOSell2,041$53.19$108,560.792,041View SEC Filing  
5/13/2016Douglas J DelaneyVPSell12,299$46.60$573,133.402,042View SEC Filing  
5/13/2016Michael R DavinCEOSell26,271$46.59$1,223,965.894,221View SEC Filing  
5/13/2016Timothy W BakerCFOSell12,451$46.60$580,216.602,042View SEC Filing  
4/18/2016Douglas J DelaneyVPSell15,890$45.01$715,208.9011,807View SEC Filing  
4/18/2016Michael R DavinCEOSell74,729$45.31$3,385,970.9924,575View SEC Filing  
4/18/2016Timothy W BakerCFOSell14,008$45.02$630,640.169,925View SEC Filing  
4/14/2016Douglas J DelaneyVPSell24,488$45.02$1,102,449.768,100View SEC Filing  
4/14/2016Michael R DavinCEOSell61,377$45.01$2,762,578.771,604View SEC Filing  
4/14/2016Timothy W BakerCFOSell39,857$45.02$1,794,362.148,107View SEC Filing  
4/13/2016Michael R DavinCEOSell72$45.00$3,240.0072View SEC Filing  
4/6/2016Douglas J DelaneyVPSell4,408$45.08$198,712.642,508View SEC Filing  
4/6/2016Michael R DavinCEOSell4,869$45.11$219,640.592,969View SEC Filing  
4/6/2016Timothy W BakerCFOSell4,413$45.08$198,938.042,520View SEC Filing  
4/4/2016Douglas J DelaneyVPSell66,626$45.47$3,029,484.227,233View SEC Filing  
4/4/2016Michael R DavinCEOSell66,259$45.61$3,022,072.998,680View SEC Filing  
4/4/2016Timothy W BakerCFOSell53,297$45.60$2,430,343.209,496View SEC Filing  
12/31/2015Michael R. DavinCEOSell200$45.00$9,000.00View SEC Filing  
12/31/2015Timothy W. BakerCFOSell100$45.00$4,500.00View SEC Filing  
6/1/2015Ettore V BiagioniDirectorSell24,000$36.25$870,000.00View SEC Filing  
5/20/2015Douglas J DelaneyVPSell89,000$38.01$3,382,890.00View SEC Filing  
5/20/2015Michael R DavinCEOSell151,000$38.07$5,748,570.00View SEC Filing  
4/23/2015Michael R DavinCEOSell6,991$33.04$230,982.64View SEC Filing  
4/10/2015Michael R DavinCEOSell44,677$33.01$1,474,787.77View SEC Filing  
4/9/2015Douglas J DelaneyVPSell28,335$33.01$935,338.35View SEC Filing  
4/9/2015Michael R DavinCEOSell70,000$32.00$2,240,000.00View SEC Filing  
4/8/2015Douglas J DelaneyVPSell45,000$32.00$1,440,000.00View SEC Filing  
1/9/2015Ettore V BiagioniDirectorSell12,000$30.09$361,080.00View SEC Filing  
12/2/2014Ettore V BiagioniDirectorSell2,500$28.00$70,000.00View SEC Filing  
11/24/2014Ettore V BiagioniDirectorSell5,000$27.28$136,400.00View SEC Filing  
11/5/2013Marina HatsopoulosDirectorBuy3,000$22.60$67,800.003,000View SEC Filing  
9/5/2012Douglas J DelaneyVPSell16,904$27.65$467,395.60View SEC Filing  
9/5/2012Michael R DavinCEOSell16,770$27.65$463,690.50View SEC Filing  
9/5/2012Timothy W BakerCFOSell16,854$27.65$466,013.10View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cynosure (NASDAQ CYNO) News Headlines

Source:
DateHeadline
Global Surgical Lasers Market Growth Opportunities: Cynosure Inc., Lumenis, Biolitec AG, Abbott LaboratoriesGlobal Surgical Lasers Market Growth Opportunities: Cynosure Inc., Lumenis, Biolitec AG, Abbott Laboratories
www.marketwatch.com - May 16 at 9:44 AM
Global Surgical Lasers Market Opportunities 2018: Cynosure Inc., Abbott Laboratories, BISON MEDICAL Co. LtdGlobal Surgical Lasers Market Opportunities 2018: Cynosure Inc., Abbott Laboratories, BISON MEDICAL Co. Ltd
www.marketwatch.com - March 14 at 10:30 AM
Head-To-Head Survey: Cynosure (CYNO) & Koninklijke Philips (PHG)Head-To-Head Survey: Cynosure (CYNO) & Koninklijke Philips (PHG)
www.americanbankingnews.com - February 15 at 3:18 AM
Financial Contrast: Danaher (DHR) versus Cynosure (CYNO)Financial Contrast: Danaher (DHR) versus Cynosure (CYNO)
www.americanbankingnews.com - January 20 at 1:16 PM
Federal judge says jurisdiction lacking in Cynosure lawsuitFederal judge says jurisdiction lacking in Cynosure lawsuit
www.reuters.com - January 18 at 9:49 AM
Hologic Preliminary Revenues Increase 8% to Approximately $791 Million in the ...Hologic Preliminary Revenues Increase 8% to Approximately $791 Million in the ...
www.prnewswire.com - January 9 at 5:29 PM
Restoration Robotics® Announces Appointment of Chris Aronson as Vice President of Sales - NasdaqRestoration Robotics® Announces Appointment of Chris Aronson as Vice President of Sales - Nasdaq
www.nasdaq.com - January 5 at 5:08 PM
Contrasting Varian Medical Systems (VAR) and Cynosure (CYNO)Contrasting Varian Medical Systems (VAR) and Cynosure (CYNO)
www.americanbankingnews.com - December 29 at 3:22 PM
Auto Sales to Advance on Strong Economy, China GrowthAuto Sales to Advance on Strong Economy, China Growth
www.zacks.com - December 20 at 5:20 PM
Cowen: Hologic Is A Relatively Cheap Stock Overdue For Upside - BenzingaCowen: Hologic Is A Relatively Cheap Stock Overdue For Upside - Benzinga
www.benzinga.com - December 11 at 5:34 PM
Hologic (HOLX) Up 8% Since Earnings Report: Can It Continue?Hologic (HOLX) Up 8% Since Earnings Report: Can It Continue?
www.nasdaq.com - December 11 at 10:12 AM
Non-Invasive Fat Reduction Market - Global Industry Analysis, Size, Share ...Non-Invasive Fat Reduction Market - Global Industry Analysis, Size, Share ...
www.prnewswire.com - November 21 at 11:03 PM
Facial Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022Facial Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022
www.prnewswire.com - November 20 at 11:44 PM
Head-To-Head Contrast: Cynosure (CYNO) versus The CompetitionHead-To-Head Contrast: Cynosure (CYNO) versus The Competition
www.americanbankingnews.com - November 19 at 11:36 AM
Hologic (HOLX) Q4 2017 Results - Earnings Call TranscriptHologic (HOLX) Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - November 9 at 12:22 AM
Tattoo Removal Market - Global Opportunity Analysis and Industry Forecast, 2017-2023Tattoo Removal Market - Global Opportunity Analysis and Industry Forecast, 2017-2023
www.bizjournals.com - November 4 at 6:54 AM
Head-To-Head Review: Cynosure (CYNO) versus The CompetitionHead-To-Head Review: Cynosure (CYNO) versus The Competition
www.americanbankingnews.com - November 2 at 11:30 AM
Can Molecular Diagnostics Drive Hologics (HOLX) Q4 Earnings?Can Molecular Diagnostics Drive Hologic's (HOLX) Q4 Earnings?
www.nasdaq.com - November 1 at 6:39 PM
Non-Surgical Skin Tightening Market to reach US$ 500 Mn by 2022 - Transparency Market ResearchNon-Surgical Skin Tightening Market to reach US$ 500 Mn by 2022 - Transparency Market Research
globenewswire.com - October 25 at 7:22 PM
Non-invasive Fat Reduction Market Worth US$2.50 Billion by 2025, Globally: Transparency Market ResearchNon-invasive Fat Reduction Market Worth US$2.50 Billion by 2025, Globally: Transparency Market Research
www.marketwatch.com - October 25 at 7:22 PM
Global $26.5 Billion Medical Aesthetics Market to 2024 - Research and Markets - Business Wire (press release)Global $26.5 Billion Medical Aesthetics Market to 2024 - Research and Markets - Business Wire (press release)
www.businesswire.com - October 24 at 8:07 PM
Global Non-Surgical Fat Reduction Market to Incur Valuation of US$ 220 Mn by 2022 - Future Market InsightsGlobal Non-Surgical Fat Reduction Market to Incur Valuation of US$ 220 Mn by 2022 - Future Market Insights
www.marketwatch.com - October 23 at 6:14 PM
Facial Treatment Market to be Driven by Rising Prevalence of Dermatological ConditionsFacial Treatment Market to be Driven by Rising Prevalence of Dermatological Conditions
globenewswire.com - October 17 at 6:33 PM
3 Plastic & Reconstructive Surgery Stocks Looking Good - Nasdaq3 Plastic & Reconstructive Surgery Stocks Looking Good - Nasdaq
www.nasdaq.com - October 12 at 11:34 PM
3 Plastic & Reconstructive Surgery Stocks Looking Good3 Plastic & Reconstructive Surgery Stocks Looking Good
finance.yahoo.com - October 11 at 7:12 PM
Critical Review: Cynosure (CYNO) versus Intuitive Surgical (ISRG)Critical Review: Cynosure (CYNO) versus Intuitive Surgical (ISRG)
www.americanbankingnews.com - October 1 at 4:38 PM
Hologic (HOLX) Granted FDA 510(k) Clearance to Market SculpSure for Non-Invasive Body Contouring (Lipolysis) of the Submental AreaHologic (HOLX) Granted FDA 510(k) Clearance to Market SculpSure for Non-Invasive Body Contouring (Lipolysis) of the Submental Area
www.streetinsider.com - September 27 at 6:50 PM
Hologic Receives FDA 510(k) Clearance to Market SculpSure® for Non-Invasive ...Hologic Receives FDA 510(k) Clearance to Market SculpSure® for Non-Invasive ...
www.prnewswire.com - September 27 at 6:50 PM
Hologic Receives FDA 510(k) Clearance to Market SculpSure® for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the Chin)Hologic Receives FDA 510(k) Clearance to Market SculpSure® for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the Chin)
www.bizjournals.com - September 27 at 6:50 PM
Cosmetic Procedures Market to Reach US$ 51.6 Billion by 2022 – Persistence Market ResearchCosmetic Procedures Market to Reach US$ 51.6 Billion by 2022 – Persistence Market Research
globenewswire.com - September 27 at 6:50 PM
Trumps Pick for Federal Reserves Top Regulator Just Won This BattleTrump's Pick for Federal Reserve's Top Regulator Just Won This Battle
www.thestreet.com - September 8 at 6:07 PM
Cutera Strengthens Leadership Team with Two Key Executive Appointments - NasdaqCutera Strengthens Leadership Team with Two Key Executive Appointments - Nasdaq
www.nasdaq.com - August 21 at 10:26 PM
Global Aesthetic Laser Market 2017-2023 - Leading Companies Cynosure, Lumenis, Cutera, Alma Lasers & Sciton - Research and MarketsGlobal Aesthetic Laser Market 2017-2023 - Leading Companies Cynosure, Lumenis, Cutera, Alma Lasers & Sciton - Research and Markets
www.businesswire.com - August 19 at 4:57 PM
Global Aesthetic Laser Market 2017-2023 - Leading Companies ... - Business Wire (press release)Global Aesthetic Laser Market 2017-2023 - Leading Companies ... - Business Wire (press release)
www.businesswire.com - August 18 at 5:44 PM
Analyzing Derma Sciences (DSCI) & Cynosure (CYNO)Analyzing Derma Sciences (DSCI) & Cynosure (CYNO)
www.americanbankingnews.com - August 3 at 8:29 AM
Hologic (HOLX) Q3 2017 Results - Earnings Call TranscriptHologic (HOLX) Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - August 2 at 11:37 PM
Hologic Announces Financial Results for Third Quarter of Fiscal 2017Hologic Announces Financial Results for Third Quarter of Fiscal 2017
www.bizjournals.com - August 2 at 6:37 PM
Trumps Wall Street Watchdogs to Shed Millions Invested in Banks - BloombergTrump's Wall Street Watchdogs to Shed Millions Invested in Banks - Bloomberg
www.bloomberg.com - July 25 at 5:42 PM
Whats in the Offing for Hologic (HOLX) in Q3 Earnings? - NasdaqWhat's in the Offing for Hologic (HOLX) in Q3 Earnings? - Nasdaq
www.nasdaq.com - July 24 at 10:46 AM
Medical Aesthetics Market to Reach $19.4 Billion by 2023: P&S Market ResearchMedical Aesthetics Market to Reach $19.4 Billion by 2023: P&S Market Research
globenewswire.com - July 19 at 11:56 PM
Hologic: Growth Cheaply Priced - Seeking AlphaHologic: Growth Cheaply Priced - Seeking Alpha
seekingalpha.com - July 16 at 9:42 AM
Revolving Door Spins Ex-Carlyle Deal-Maker Into Key Fed RoleRevolving Door Spins Ex-Carlyle Deal-Maker Into Key Fed Role
www.bloomberg.com - July 12 at 11:27 PM
Trumps Fed Nominee Has History of Benefiting From Bailouts - New York TimesTrump's Fed Nominee Has History of Benefiting From Bailouts - New York Times
www.nytimes.com - July 12 at 6:24 PM
Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure ...Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure ...
www.prnewswire.com - June 15 at 6:33 PM
Global Cellulite Treatment Market - Industry Forecast to 2025 - Analysis By Treatment, End User & Geography - Research and MarketsGlobal Cellulite Treatment Market - Industry Forecast to 2025 - Analysis By Treatment, End User & Geography - Research and Markets
www.finanznachrichten.de - June 8 at 5:39 PM
Global Anti-Aging Market Size & Trends Will Reach $216.52 Billion by 2021: Zion Market ResearchGlobal Anti-Aging Market Size & Trends Will Reach $216.52 Billion by 2021: Zion Market Research
www.benzinga.com - June 5 at 11:54 AM
Global Medical Aesthetics Market to Reach $13 Billion by 2021 - Analysis By Product, End User & Region - Research and MarketsGlobal Medical Aesthetics Market to Reach $13 Billion by 2021 - Analysis By Product, End User & Region - Research and Markets
www.finanznachrichten.de - May 29 at 4:45 PM
Asia-Pacific Aesthetic Lasers and Energy Devices Market Outlook to 2023Asia-Pacific Aesthetic Lasers and Energy Devices Market Outlook to 2023
www.bizjournals.com - May 16 at 4:39 PM

SEC Filings

Cynosure (NASDAQ:CYNO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cynosure (NASDAQ:CYNO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cynosure (NASDAQ CYNO) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.